Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
How do I know which shot is right for me
FOLIC ACID and VITAMIN B12 act in synergy in the formation of DNA , and deficiencies can have serious consequences, both in performance horses with a high tissue turnover rate, and in pregnancy and growth of young foals
Audits can take various forms, from unannounced spot checks to formal, scheduled reviews
Start a detailed symptom diary to present to your GP
Early work focused on the hGH fragment 177191, which was later modified by adding a tyrosine residue, leading to the development of AOD 9604
US$ 25.77
US$ 24.85
US$ 24.78
US$ 21.26
US$ 24.82
US$ 23.00
US$ 22.52
